Log in
Enquire now
‌

US Patent 10677803 Method of assessing risk of PML

Patent 10677803 was granted and assigned to Biogen on June, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Biogen
Biogen
0
Date Filed
August 28, 2018
0
Date of Patent
June 9, 2020
0
Patent Applicant
Biogen
Biogen
0
Patent Application Number
16115350
0
Patent Citations Received
‌
US Patent 12105090 Methods of treating a multiple sclerosis patient with anti-VLA-4 therapy
0
‌
US Patent 11292845 Methods of treating inflammatory and autoimmune diseases with natalizumab
‌
US Patent 11333670 Methods of treating inflammatory and autoimmune diseases with natalizumab
‌
US Patent 12066442 Method of assessing risk of PML
0
‌
US Patent 11280794 Method of assessing risk of PML
‌
US Patent 11287423 Assay for JC virus antibodies
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10677803
0
Patent Primary Examiner
‌
Barry A Chestnut
0

Find more entities like US Patent 10677803 Method of assessing risk of PML

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.